File ID,Assessment,Summary,Subjective,Objective,Summary_lemma,Summary_expanded,Summary_umls,Summary_lemma_umls,Summary_expanded_umls,cleaned_expanded_Summary,terms,hypertension,acute renal failure,atrial fibrillation,anemia,coronary artery disease,hypotension,altered mental status,respiratory failure,diabetes mellitus,leukocytosis,is_respiratory_failure_baseline,is_respiratory_failure_baseline_reasoning,is_respiratory_failure_ltm,is_respiratory_failure_ltm_reasoning
101616.txt,"67 y/o M CAD s/[**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] [**Last Name (Prefixes) **] stent [**2169-11-15**] with recent cecum polypectomy
   who presents with bright red blood per rectum and hypotension following
   prep.
   .",Lower GI bleed; Hypotension; CAD,"COLONOSCOPY - At [**2171-1-25**] 12:31 PM
- Colonoscopy: ulceration with 2 visible vessels at prior polypectomy
site. 2 clips placed for hemostasis; small rectal ulcers; grade 2
internal hemorrhoids
- GI recs: c/w clear liquids x 1 day; no plavix/ASA x 48 hrs; c/w
following Hcts
- Hct: 34.4 -> 34.1 -> 33.7
- Plt: 127 -> 122 -> 115
- [**Hospital 1303**] Hosp records obtained to clarify iodine allergy:
""   Only mentions lumbar myelogram on [**2155-9-19**]: """"the patient tolerated the""
""   procedure well.""""""
History obtained from Patient
History obtained from PatientIodine; Iodine Containing
severe leg pain
Review of systems is unchanged from admission except as noted below
Review of systems:","Last dose of Antibiotics:
Infusions:
Other ICU medications:
Midazolam (Versed) - [**2171-1-25**] 01:40 PM
Fentanyl - [**2171-1-25**] 01:45 PM
Other medications:
Flowsheet Data as of  [**2171-1-26**] 07:17 AM
Vital signs
Hemodynamic monitoring
Fluid balance
24 hours
Since [**72**] AM
Tmax: 37
C (98.6
Tcurrent: 35.8
C (96.5
HR: 53 (45 - 88) bpm
BP: 157/65(85) {120/55(71) - 157/96(103)} mmHg
RR: 17 (8 - 22) insp/min
SpO2: 93%
Heart rhythm: SB (Sinus Bradycardia)
Height: 68 Inch
Total In:
1,861 mL
PO:
1,150 mL
TF:
IVF:
40 mL
Blood products:
671 mL
Total out:
1,000 mL
800 mL
Urine:
1,000 mL
800 mL
NG:
Stool:
Drains:
Balance:
861 mL
-800 mL
Respiratory support
O2 Delivery Device: None
SpO2: 93%
ABG: ///25/
General Appearance: Well nourished, No acute distress
Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
Present), (Right DP pulse: Present), (Left DP pulse: Present)
Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Clear : )
Abdominal: Soft, Non-tender, Bowel sounds present
Extremities: Right lower extremity edema: Absent, Left lower extremity
edema: Absent
Skin:  Warm
Neurologic: Attentive, Follows simple commands, Responds to: Verbal
stimuli, Oriented (to): x3, Movement: Purposeful, Tone: Normal
111 K/uL
11.8 g/dL
95 mg/dL
0.9 mg/dL
25 mEq/L
3.8 mEq/L
10 mg/dL
113 mEq/L
143 mEq/L
34.0 %
5.8 K/uL
[image002.jpg]
[**2171-1-25**]  04:23 AM
[**2171-1-25**]  07:44 AM
[**2171-1-25**]  01:29 PM
[**2171-1-25**]  09:14 PM
[**2171-1-26**]  05:30 AM
WBC
9.4
6.3
6.4
5.8
Hct
35.7
34.4
34.1
33.7
34.0
Plt
127
122
115
111
Cr
1.0
0.9
Glucose
102
95
Other labs: PT / PTT / INR:12.6/25.6/1.1, ALT / AST:16/25, Alk Phos / T
Bili:43/2.5, LDH:297 IU/L, Ca++:7.9 mg/dL, Mg++:2.1 mg/dL, PO4:2.4
mg/dL
Imaging: [**1-25**] Colonoscopy: Ulcer in the colon (endoclip)
Ulcers in the rectum
Grade 2 internal hemorrhoids
Otherwise normal colonoscopy to cecum",low gi bleed ; hypotension ; cad,Lower Gastrointestinal bleed; Hypotension; Coronary Artery Disease,Lower GI bleeding;Hypotension NEC,hypotensive;gi bleed,Coronary Artery Disease;Gastrointestinal bleed,lower gastrointestinal bleed; hypotension; coronary artery disease,"['lower gastrointestinal bleed', 'hypotension', 'coronary artery disease']",False,False,False,False,True,True,False,False,False,False,False,"To determine if the patient is diagnosed with respiratory failure, we need to analyze the provided subjective and objective data. The patient's history and recent colonoscopy results are noted, but the key information for diagnosing respiratory failure lies in the vital signs, hemodynamic monitoring, and respiratory support data. The patient's respiratory rate (RR) is 17 breaths per minute, which is within the normal range (12-20 breaths per minute for adults). The oxygen saturation (SpO2) is 93% on room air, which, although slightly below the normal range (>95%), does not necessarily indicate respiratory failure without other supporting evidence. The patient is not on any oxygen delivery device, and there's no mention of respiratory distress or abnormal breath sounds in the general appearance and respiratory/chest examination. Furthermore, the arterial blood gas (ABG) results are not fully provided, but the absence of significant abnormalities in the vital signs and the lack of respiratory support suggest that the patient is not in overt respiratory failure. While the patient's condition could be monitored for potential development of respiratory issues, the current data do not support a diagnosis of respiratory failure.",False,"To determine if the patient is experiencing respiratory failure, we need to analyze the provided subjective and objective data in the context of the long-term memory on respiratory failure. The patient's history, vital signs, laboratory results, and physical examination findings are crucial for this assessment. From the subjective report, there's no direct mention of symptoms typically associated with respiratory failure such as shortness of breath, worsening respiratory status, or specific concerns regarding oxygen saturation or respiratory rate. However, the patient did undergo a colonoscopy, which might have some implications for respiratory status due to the procedural sedation and potential for aspiration or other respiratory complications. The objective data shows the patient's vital signs, including a respiratory rate (RR) of 17 breaths per minute, which falls within the normal range (12-20 breaths per minute for adults), and an oxygen saturation (SpO2) of 93% on room air, which is slightly below the normal range (>94% on room air). The arterial blood gas (ABG) results are not fully provided, but the presence of any acidosis or hypoxemia would be critical in diagnosing respiratory failure. The patient's white blood cell (WBC) count is within a range that could indicate a response to stress or infection but is not specifically elevated to a degree that would solely indicate respiratory failure. The patient is not on any oxygen delivery device, and the general appearance and respiratory examination (clear breath sounds, symmetric expansion) do not immediately suggest distress or failure. Considering the long-term memory, indicators of respiratory failure include worsening respiratory status, decreased oxygen saturation, and specific laboratory and imaging findings. While the patient's SpO2 is slightly decreased, other indicators such as respiratory rate, breath sounds, and the absence of reported distress or need for oxygen therapy do not strongly support a diagnosis of respiratory failure at this time. Therefore, based on the information provided and the criteria for respiratory failure, the patient does not appear to be in respiratory failure."
102486.txt,"81F with h/o chronic eosinophilic lung disease, COPD, diastolic CHF,
   and recent admission for MSSA and pan-sensitive Pseudomonas PNA who
   presents with fevers, right sided pleuritic chest pain and found to
   have extensive R sided PE on imaging.","PULMONARY EMBOLISM; FEVER; HYPOTENSION; OLIGURIA; NON-GAP ACIDOSIS; HISTORY OF EOSINOPHILIC LUNG DISEASE; DEEP VENOUS THROMBOSIS (DVT), LOWER EXTREMITY; H/O CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD, BRONCHITIS,
   EMPHYSEMA) WITH ACUTE EXACERBATION; HEART FAILURE (CHF), DIASTOLIC, CHRONIC","Pleuritic right chest pain
- patient started on coumadin
- [** 949**] briefly decreased (although unclear whether this was due to
accidental foley removal), [** 949**] responded appropriately to 500 ml LR
bolus with [** 949**] 60-70 cc
s per hour this am
- patient briefly developed non-gap acidosis with bicarb of 19,
resolved with substitution of LR for NS for fluid boluses
S: The patient is feeling well.  Her chest pain has entirely resolved.
She continues to have dry-mouth as well as her baseline amount of cough
and shortness or breath.  She has not had N/V diarrhea.  No pain or
swelling in her legs.
Losartan
angioedema/lip
Lisinopril (Oral)
Cough;
Penicillins
itching;
Flagyl (Oral) (Metronidazole)
Wheezing;
Ultram (Oral) (Tramadol Hcl)
Rash;
Review of systems is unchanged from admission except as noted below
Review of systems:","Last dose of Antibiotics:
Ciprofloxacin - [**2141-7-18**] 08:00 PM
Vancomycin - [**2141-7-19**] 08:02 AM
Infusions:
Heparin Sodium - 850 units/hour
Other ICU medications:
Other medications:
Flowsheet Data as of  [**2141-7-20**] 07:16 AM
Vital signs
Hemodynamic monitoring
Fluid balance
24 hours
Since 12 AM
Tmax: 36.9
C (98.4
Tcurrent: 36.4
C (97.6
HR: 80 (73 - 94) bpm
BP: 99/55(67) {82/37(35) - 125/73(89)} mmHg
RR: 18 (18 - 28) insp/min
SpO2: 98%
Heart rhythm: SR (Sinus Rhythm)
Height: 63 Inch
Total In:
2,315 mL
690 mL
PO:
270 mL
60 mL
TF:
IVF:
2,045 mL
630 mL
Blood products:
Total out:
700 mL
250 mL
Urine:
700 mL
250 mL
NG:
Stool:
Drains:
Balance:
1,615 mL
440 mL
Respiratory support
O2 Delivery Device: Nasal cannula
SpO2: 98%
ABG: ///22/
Gen: Elderly woman in NAD, sleeping comfortable
HEENT: dry MMM, no JVD
CV: RRR, no murmurs
Lungs: Decreased breath sounds throughout, lungs otherwise clear
Abd: Soft, non-tender, +bowel sounds
Ext: Warm and well-perfused, no edema or tenderness
Neuro: Responds appropriately to questions, grossly non-focal
293 K/uL
8.1 g/dL
101 mg/dL
0.6 mg/dL
22 mEq/L
3.2 mEq/L
9 mg/dL
111 mEq/L
143 mEq/L
25.0 %
8.3 K/uL
[image002.jpg]
[**2141-7-18**]  08:16 PM
[**2141-7-19**]  04:10 AM
[**2141-7-20**]  02:55 AM
WBC
10.6
8.3
Hct
24.7
25.0
Plt
269
293
Cr
0.8
0.6
TropT
0.01
<0.01
Glucose
99
101
Other labs: PT / PTT / INR:15.3/56.2/1.3, CK / CKMB /
Troponin-T:31/3/<0.01, Differential-Neuts:77.2 %, Lymph:17.6 %,
Mono:4.6 %, Eos:0.5 %, Lactic Acid:1.1 mmol/L, Ca++:7.3 mg/dL, Mg++:2.0
mg/dL, PO4:1.7 mg/dL","pulmonary embolism ; fever ; hypotension ; oliguria ; non-gap acidosis ; history of eosinophilic lung disease ; deep venous thrombosis ( dvt ) , low extremity ; h/o chronic obstructive pulmonary disease ( copd , bronchitis , emphysema ) with acute exacerbation ; heart failure ( chf ) , diastolic , chronic","PULMONARY EMBOLISM; FEVER; HYPOTENSION; OLIGURIA; NON-GAP ACIDOSIS; HISTORY OF EOSINOPHILIC LUNG DISEASE; DEEP VENOUS THROMBOSIS (DEEP VENOUS THROMBOSIS), LOWER EXTREMITY; HISTORY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BRONCHITIS, EMPHYSEMA) WITH ACUTE EXACERBATION; HEART FAILURE (CONGESTIVE HEART FAILURE), DIASTOLIC, CHRONIC",chronic uti;eosinophilic lung;Non-gap acidosis;Chr pulmonary embolism;oliguria;edema lower extremity;deep venous thrombosis;Acute exacerbation of chronic heart failure;bronchitis emphysema;chronic obstructive pulmonary disease;hypotensive,extremity edema;chronic uti;eosinophilic lung;Non-gap acidosis;Chr pulmonary embolism;oliguria;deep venous thrombosis;Acute exacerbation of chronic heart failure;bronchitis emphysema;chronic obstructive pulmonary disease;hypotensive,chronic uti;chronic disease;acute exacerbation copd;eosinophilic lung;Non-gap acidosis;Chr pulmonary embolism;oliguria;lower extremity ulcer;congestive heart failure (CHF);deep venous thrombosis;Obstructive pulmonary disease;emphysema;disease;chronic obstructive pulmonary disease;hypotensive,pulmonary embolism; fever; hypotension; oliguria; non gap acidosis; history of eosinophilic lung disease; deep venous thrombosis deep venous thrombosis lower extremity; history of chronic obstructive pulmonary disease chronic obstructive pulmonary disease bronchitis emphysema with acute exacerbation; heart failure congestive heart failure diastolic chronic,"['pulmonary embolism', 'fever', 'hypotension', 'oliguria', 'non gap acidosis', 'history of eosinophilic lung disease', 'deep venous thrombosis deep venous thrombosis lower extremity', 'history of chronic obstructive pulmonary disease chronic obstructive pulmonary disease bronchitis emphysema with acute exacerbation', 'heart failure congestive heart failure diastolic chronic']",False,False,False,False,False,True,False,False,False,False,False,"To determine if the patient is diagnosed with respiratory failure, we need to analyze the provided subjective and objective data. The patient initially presented with pleuritic right chest pain but now reports that the chest pain has entirely resolved. However, the patient continues to experience dry mouth, baseline cough, and shortness of breath. These symptoms could be indicative of respiratory issues but are not exclusively diagnostic of respiratory failure. The patient's vital signs show a respiratory rate (RR) of 18 breaths per minute, which is within the normal range (12-20 breaths per minute for adults), and an SpO2 of 98% on a nasal cannula, indicating adequate oxygenation. The arterial blood gas (ABG) results are not fully provided, but the fact that the patient is on a nasal cannula with an SpO2 of 98% suggests that they are not in severe respiratory distress at the moment. The lungs are described as having decreased breath sounds throughout but are otherwise clear, which could indicate a respiratory issue but does not specifically point to respiratory failure. The patient's laboratory results, including a normal white blood cell count and differential, do not strongly suggest an acute infectious process that could lead to respiratory failure. The patient is also on heparin and has been on antibiotics (Ciprofloxacin and Vancomycin), which could be for a variety of reasons, including prevention of hospital-acquired infections or treatment of an existing infection, but the specific indication is not provided. Given the information, while the patient has some respiratory symptoms and findings, the current data do not strongly support a diagnosis of respiratory failure, especially considering the patient's ability to maintain adequate oxygenation on a relatively low level of supplemental oxygen and the absence of severe respiratory distress or failure indicators such as hypercapnia or significant hypoxemia.",False,"To determine if the patient is experiencing respiratory failure, we need to analyze the provided subjective and objective data in the context of the long-term memory on respiratory failure. The patient reports pleuritic right chest pain, which has since resolved, and continues to experience dry mouth, cough, and shortness of breath. These symptoms could be indicative of respiratory issues but are not exclusively diagnostic of respiratory failure. The patient's history of being on coumadin and experiencing brief non-gap acidosis, which resolved with a change in fluid bolus from NS to LR, suggests some level of metabolic and possibly respiratory compensation. However, the resolution of acidosis and the patient's current comfort and stable vital signs (HR: 80 bpm, BP: 99/55 mmHg, RR: 18 insp/min, SpO2: 98% on nasal cannula) do not strongly indicate acute respiratory failure. The decreased breath sounds throughout the lungs could be a sign of an underlying respiratory issue, but without further evidence of worsening respiratory status, hypoxemia, or hypercapnia (as might be indicated by ABG results, which are not fully provided), it's challenging to conclude respiratory failure solely based on this finding. The patient's laboratory results, including a normal white blood cell count and lack of significant abnormalities in troponin or lactic acid levels, do not strongly support a diagnosis of respiratory failure. Considering the information provided and comparing it against the indicators of respiratory failure from the long-term memory, such as worsening respiratory status, decreased oxygen saturation, and specific laboratory findings indicative of acidosis and hypoxemia, the patient does not exhibit clear signs of respiratory failure at this time."
198989.txt,"79 yo F w/ a h/o CHF (EF of 20-30%), carotid stenosis, no CAD from cath
   [**2-1**], and h/o LBBB s/p BiV pacer presents as OSH transfer with ?Sepsis
   [**1-25**] UTI, atrial fibrillation w/ RVR and demand ischemia.","Sepsis; Altered/Depressed MS
 thought to be [**1-25**] to ativan yesterday,; # Acute on Chronic Renal Failure; supertherapeutic INR; Afib, now rate controlled - likely worsened by underlying
   sepsis; s/p BiV placement [**8-31**].; demand ischemia","- ID: rec bedside echo
- continued fluid bolus
- BB downtitrated from Q6 to [**Hospital1 **]
- FeNa of 0.17, random cortisol was normal.
Morphine
Rash;
Demerol (Oral) (Meperidine Hcl)
Confusion/Delir
Levaquin (Oral) (Levofloxacin)
Unknown;
Benadryl (Injection) (Diphenhydramine Hcl)
Confusion/Delir
Cymbalta (Oral) (Duloxetine Hcl)
Unknown;
Celexa (Oral) (Citalopram Hydrobromide)
Unknown;
Remeron (Oral) (Mirtazapine)
Unknown;
Sulfa (Sulfonamide Antibiotics)
Unknown;
Quinolones
Unknown;
Vancomycin
Rash;
Review of systems is unchanged from admission except as noted below
Review of systems:","Last dose of Antibiotics:
Metronidazole - [**2168-11-8**] 08:00 AM
Meropenem - [**2168-11-9**] 12:00 AM
Infusions:
Other ICU medications:
Other medications:
Changes to
Flowsheet Data as of  [**2168-11-10**] 07:26 AM
Vital signs
Hemodynamic monitoring
Fluid balance
24 hours
Since 12 AM
Tmax: 36.9
C (98.4
Tcurrent: 36.9
C (98.4
HR: 75 (70 - 79) bpm
BP: 102/68(74) {89/31(46) - 119/68(74)} mmHg
RR: 17 (15 - 33) insp/min
SpO2: 99%
Heart rhythm: V Paced
Wgt (current): 75 kg (admission): 63 kg
Height: 64 Inch
CVP: 14 (9 - 14)mmHg
Total In:
2,713 mL
409 mL
PO:
TF:
1,073 mL
335 mL
IVF:
840 mL
74 mL
Blood products:
Total out:
680 mL
310 mL
Urine:
680 mL
310 mL
NG:
Stool:
Drains:
Balance:
2,033 mL
99 mL
Respiratory support
O2 Delivery Device: Nasal cannula
SpO2: 99%
ABG: ///19/
Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
Not assessed)
Skin:  Not assessed
Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
Not assessed
200 K/uL
8.5 g/dL
146 mg/dL
2.1 mg/dL
19 mEq/L
4.3 mEq/L
90 mg/dL
111 mEq/L
139 mEq/L
26.0 %
22.4 K/uL
[image002.jpg]
[**2168-11-5**]  09:14 PM
[**2168-11-6**]  04:57 AM
[**2168-11-7**]  04:41 AM
[**2168-11-7**]  12:00 PM
[**2168-11-7**]  05:00 PM
[**2168-11-8**]  03:20 AM
[**2168-11-8**]  04:57 PM
[**2168-11-8**]  10:55 PM
[**2168-11-9**]  03:29 AM
[**2168-11-10**]  04:27 AM
WBC
14.5
21.9
24.5
20.4
22.5
22.4
Hct
27.4
28.3
26.2
26.4
23.0
25.3
24.5
26.0
Plt
101
124
129
135
149
200
Cr
2.3
2.6
2.9
2.6
2.5
2.4
2.3
2.1
Glucose
175
169
76
90
106
87
97
96
114
146
Other labs: PT / PTT / INR:54.6/44.0/6.1, ALT / AST:44/41, Alk Phos / T
Bili:101/0.6, Differential-Neuts:93.0 %, Band:0.0 %, Lymph:5.0 %,
Mono:1.0 %, Eos:0.0 %, Fibrinogen:622 mg/dL, Lactic Acid:2.0 mmol/L,
Albumin:2.3 g/dL, LDH:194 IU/L, Ca++:8.2 mg/dL, Mg++:2.7 mg/dL, PO4:3.9
mg/dL
TE: The left atrium is mildly dilated. Left ventricular wall
thicknesses are normal. The left ventricular cavity is moderately
dilated. There is severe global left ventricular hypokinesis (LVEF =
20-25 %). [Intrinsic left ventricular systolic function is likely more
depressed given the severity of valvular regurgitation.] Right
ventricular chamber size is normal. with focal hypokinesis of the
apical free wall. The aortic valve leaflets (3) are mildly thickened.
There is mild aortic valve stenosis (valve area 1.2-1.9cm2). Mild (1+)
aortic regurgitation is seen. The mitral valve leaflets are mildly
thickened. Moderate to severe (3+) mitral regurgitation is seen. [Due
to acoustic shadowing, the severity of mitral regurgitation may be
significantly UNDERestimated.] Moderate [2+] tricuspid regurgitation is
seen. There is moderate pulmonary artery systolic hypertension. The
pulmonic valve leaflets are thickened. There is no pericardial
effusion.
Compared with the prior study (images reviewed) of [**2168-4-20**], the left
ventricular cavity appears dilated on the current study. The degree of
mitral regurgitation has increased significantly. The degree of aortic
stenosis has incrased slightly. LV systolic function remains severely
depressed, although the ventricle does not appear as dyssynchronous as
on the prior study.
CXR: Improved pulmonary edema which is now mild with stable left
perihilar opacity, worsened since [**2168-11-6**] and is most likely
consolidation, probably pneumonia,less likely asymmetrical pulmonary
edema.","sepsis ; altered/depressed m thought to be [ * * 1-25 * * ] to ativan yesterday , ; # acute on chronic renal failure ; supertherapeutic inr ; afib , now rate control - likely worsen by underlie sepsis ; s/p biv placement [ * * 8-31 * * ] . ; demand ischemia","Sepsis; Altered/Depressed Mental Status thought to be [**1-25**] to ativan yesterday,; # Acute on Chronic Renal Failure; supertherapeutic International Normalized Ratio; Atrial fibrillation, now rate controlled - likely worsened by underlying sepsis; status post Biventricular placement [**8-31**].; demand ischemia",Depressed Mood;Sepsis;Demand ischemia;sepsis;Acute on Chronic Right Heart Failure,acute on chronic renal failure;Demand ischemia;afib;depressed;sepsis,Altered Mental Status;Sepsis;Demand ischemia;alternation;Biventricular failure;Atrial fibrillation;sepsis;Acute on Chronic Right Heart Failure,sepsis; altered depressed mental status thought to be to ativan yesterday ; acute on chronic renal failure; supertherapeutic international normalized ratio; atrial fibrillation now rate controlled likely worsened by underlying sepsis; status post biventricular placement ; demand ischemia,"['sepsis', 'altered depressed mental status thought to be to ativan yesterday', 'acute on chronic renal failure', 'supertherapeutic international normalized ratio', 'atrial fibrillation now rate controlled likely worsened by underlying sepsis', 'status post biventricular placement', 'demand ischemia']",False,False,True,False,False,False,False,False,False,False,False,"To determine if the patient is diagnosed with respiratory failure, we need to analyze the provided subjective and objective data. The patient's history and current presentation suggest a complex clinical picture with multiple potential issues affecting respiratory function. Key points from the subjective data include the patient's medication list, which contains several drugs that could potentially affect respiratory status or contribute to confusion/delirium, and the mention of a rash, which could be indicative of an allergic reaction. However, the subjective section lacks direct complaints related to respiratory distress. Moving to the objective data, vital signs show a respiratory rate (RR) of 17 breaths per minute, which is within the normal range (12-20 breaths per minute for adults), and an SpO2 of 99% on a nasal cannula, indicating good oxygen saturation. The patient's hemodynamic parameters, such as blood pressure and heart rate, are stable. Laboratory results show some abnormalities, including elevated white blood cell count (WBC) and slight variations in other parameters, but these are not directly indicative of respiratory failure. The echocardiogram (TE) reveals significant cardiac issues, including severe global left ventricular hypokinesis and moderate to severe mitral regurgitation, which could indirectly affect respiratory status by contributing to pulmonary congestion or edema. The chest X-ray (CXR) shows improved pulmonary edema, now mild, with a stable left perihilar opacity and possible consolidation, suggesting pneumonia or asymmetrical pulmonary edema. While these findings indicate some respiratory issues, such as pulmonary edema and possible pneumonia, the patient's current oxygen saturation is high, and there's no direct mention of respiratory distress or failure in the provided sections. Therefore, based on the information given, the patient does have some respiratory issues but does not clearly meet the criteria for respiratory failure as defined by severe impairment of gas exchange, which would typically include symptoms like severe dyspnea, significant hypoxemia (low SpO2), or hypercapnia (elevated CO2 levels) not responsive to supplemental oxygen therapy.",True,"To diagnose respiratory failure, we need to consider the patient's symptoms, medical history, and laboratory results. The patient's report shows a history of fluid bolus, which could indicate fluid overload, a potential cause of respiratory failure. The patient is also on various medications, including antibiotics, which could be related to an underlying infection. The vital signs show a respiratory rate (RR) of 17, which is within the normal range, and an oxygen saturation (SpO2) of 99% on a nasal cannula, indicating adequate oxygenation. However, the patient's chest X-ray (CXR) shows improved pulmonary edema, which is now mild, and a worsened left perihilar opacity, likely indicating consolidation or pneumonia. The echocardiogram results show severe global left ventricular hypokinesis, moderate to severe mitral regurgitation, and moderate pulmonary artery systolic hypertension, all of which can contribute to respiratory failure. The laboratory results, including arterial blood gas (ABG) and complete blood count (CBC), are not fully provided, but the white blood cell (WBC) count is elevated, indicating a potential infection. Considering these factors, we can assess the patient's risk for respiratory failure. The presence of pulmonary edema, severe left ventricular hypokinesis, and potential pneumonia, along with the need for oxygen therapy, suggests that the patient may be at risk for respiratory failure. However, the patient's current SpO2 is 99% on a relatively low level of oxygen support (nasal cannula), which does not strongly indicate severe respiratory failure at this moment. Nonetheless, the overall clinical picture, including the patient's complex medical history, signs of cardiac dysfunction, and evidence of pulmonary issues, warrants close monitoring for signs of respiratory failure."
193604.txt,"Mr. [**Known firstname 1908**] [**Known lastname 9824**] is a 74 yo Russian-speaking male with h/o ESRD on
   HD, HTN, HL, and CAD who presented with asymptomatic bradycardia.",# Bradycardia / Rhythm; #. Hypertension; # CAD; #. Chronic Kidney Disease Stage V on HD; . Peripheral Vascular Disease,"High-grade AV nodal block
- Had successful [**Company 2375**] VDD implant yesterday via axillary access.
Follow-up CXR showed no pneumothorax.
- He had lots of bleeding during procedure. Post procedure HCT = 33 .
White count elevated. [**Month (only) 60**] represent hemoconcentration s/p HD.
- Simvastatin increased to 40mg daily
- Started albuterol nebs
- Episode of chest pain yesterday morning. Rated [**5-21**] in the left
anterior chest wall and moved to the left scapula. No shortness of
breath, no diaphoresis, no nausea. No EKG changes. Lasted 30 minutes.
Nitro given x2 and improved. CK/Troponin flat. Later in afternoon had
intermittent pain associated with left scapula that was on and off for
a few hours. Again, EKG unchanged.
No Known Drug Allergies
Changes to  and f
Review of systems is unchanged from admission except as noted below
Review of systems:","Last dose of Antibiotics:
Infusions:
Other ICU medications:
Other medications:
Flowsheet Data as of  [**2169-8-12**] 06:44 AM
Vital signs
Hemodynamic monitoring
Fluid balance
24 hours
Since 12 AM
Tmax: 36.7
C (98.1
Tcurrent: 35.9
C (96.7
HR: 62 (30 - 83) bpm
BP: 150/50(77) {129/47(77) - 213/151(159)} mmHg
RR: 11 (9 - 17) insp/min
SpO2: 99%
Heart rhythm: V Paced
Wgt (current): 61.6 kg (admission): 62 kg
Height: 69 Inch
Total In:
PO:
TF:
IVF:
Blood products:
Total out:
3,000 mL
0 mL
Urine:
NG:
Stool:
Drains:
Balance:
-3,000 mL
0 mL
Respiratory support
O2 Delivery Device: Nasal cannula
SpO2: 99%
ABG: ///29/
GENERAL - well-appearing man in NAD, Oriented x3, comfortable, Mood,
affect appropriate.
HEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear,
Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No
xanthalesma.
CHEST: No pain on palpation of the right subclavian site sp PPM
attempt. No pain on palpation of the chest wall.  Dialysis catheter in
left chest wall.
NECK - supple, no thyromegaly, no JVD, no carotid bruits
LUNGS - Diffuse wheezing throughout lung fields, specifically in right
posterior lungs, resp unlabored, no accessory muscle use.  No
rales/rhonchi/crackles
HEART - PMI located in 5th intercostal space, midclavicular line.
Bradycardic normal S1, S2. No m/r/g auscultated, although difficult to
hear due to diffuse wheezing.  No thrills, lifts. No S3 or S4.
ABDOMEN - NABS, slightly distended with large kidneys palpable
bilaterally, liver palpable in center of the abdomen as likely shifted
due to kidney size, no rebound/guarding. Abd aorta not enlarged by
palpation. No abdominial bruits.
EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs), No
c/c/e. No femoral bruits.  Lower legs both newly wrapped by home nurse
due to stasis ulcers, not unwrapped at this time.  Both legs tender to
palpation.
LYMPH - no cervical, axillary, or inguinal LAD
NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength 5/5
throughout, sensation grossly intact throughout, DTRs 2+ and symmetric,
cerebellar exam intact, gait not assessed
PULSES:  Right: Carotid 2+ Femoral 2+ Popliteal Left: Carotid 2+
Femoral 2+ Popliteal 2+ (DP and PT not assessed due to wrapping)
170 K/uL
9.3 g/dL
79 mg/dL
5.6 mg/dL
29 mEq/L
4.3 mEq/L
30 mg/dL
101 mEq/L
141 mEq/L
29.6 %
8.1 K/uL
[image002.jpg]
[**2169-8-10**]  05:22 AM
[**2169-8-11**]  06:14 AM
[**2169-8-11**]  12:17 PM
[**2169-8-11**]  07:40 PM
[**2169-8-12**]  03:53 AM
WBC
6.9
7.1
13.3
8.1
Hct
31.1
31.2
33.5
29.6
Plt
188
171
206
170
Cr
5.2
7.5
5.6
TropT
0.27
0.34
Glucose
68
72
79
Other labs: PT / PTT / INR:17.2/30.6/1.5, CK / CKMB /
Troponin-T:91//0.34, Ca++:8.5 mg/dL, Mg++:1.9 mg/dL, PO4:5.0 mg/dL",# bradycardia / rhythm ; # . hypertension ; # cad ; # . chronic kidney disease stage v on hd ; . peripheral vascular disease,# Bradycardia / Rhythm; #. Hypertension; # Coronary Artery Disease; #. Chronic Kidney Disease Stage V on Hemodialysis; . Peripheral Vascular Disease,"Other Specified Peripheral Vascular Diseases;Sinus Bradycardia;Hypertension;Chronic Kidney Disease, Stage 1",Reflex bradycardia;hypertension;PVD-peripheral vascular disease;Chronic kidney disease stage 1,"Other Specified Peripheral Vascular Diseases;Sinus Bradycardia;Hypertension NOS;Coronary Disease;Chronic Kidney Disease, Stage 1",bradycardia rhythm; hypertension; coronary artery disease; chronic kidney disease stage v on hemodialysis; peripheral vascular disease,"['bradycardia rhythm', 'hypertension', 'coronary artery disease', 'chronic kidney disease stage v on hemodialysis', 'peripheral vascular disease']",True,False,False,False,True,False,False,False,False,False,False,"To determine if the patient is experiencing respiratory failure, we need to analyze the provided subjective and objective data. The patient had a recent VDD implant procedure and experienced bleeding during the procedure, which led to a low hematocrit (HCT) level of 33. The patient also had an episode of chest pain, but it was not associated with shortness of breath, diaphoresis, or nausea, and the EKG showed no changes. The patient is on nasal cannula oxygen with an SpO2 of 99%, which indicates adequate oxygenation. The respiratory rate is 11 breaths per minute, which is within the normal range. However, the patient has diffuse wheezing throughout the lung fields, specifically in the right posterior lungs, which could indicate a respiratory issue. The patient's ABG results are not fully provided, but the fact that they are on a low level of supplemental oxygen and have a normal respiratory rate suggests that they may not be in severe respiratory distress. Additionally, the patient's symptoms and lab results do not indicate severe hypoxemia or hypercapnia, which are hallmarks of respiratory failure. The patient's wheezing and need for albuterol nebs may indicate a need for closer monitoring and potential intervention for a respiratory issue, but based on the provided data, it does not appear that the patient is currently in respiratory failure.",False,"To diagnose respiratory failure, we need to consider the patient's symptoms, medical history, and laboratory results. The patient has a history of high-grade AV nodal block and recently underwent a VDD implant procedure. The follow-up CXR showed no pneumothorax, but the patient had significant bleeding during the procedure, resulting in a low hematocrit (HCT) of 33. The patient also has an elevated white blood cell count, which could indicate infection or inflammation. The patient experienced an episode of chest pain, which was treated with nitroglycerin, but there were no EKG changes or elevations in CK or troponin levels. The patient is currently receiving oxygen therapy via a nasal cannula and has a SpO2 of 99%. The patient's respiratory rate is 11 breaths per minute, which is within normal limits. However, the patient has diffuse wheezing throughout the lung fields, specifically in the right posterior lungs, which could indicate respiratory distress. The patient's ABG results are not fully reported, but the presence of wheezing and the need for oxygen therapy suggest potential respiratory issues. Considering the patient's medical history, symptoms, and laboratory results, we need to evaluate whether these findings are indicative of respiratory failure. Respiratory failure is characterized by inadequate oxygenation or ventilation, which can be caused by various factors, including lung disease, heart failure, or other conditions. The patient's wheezing, oxygen therapy, and elevated white blood cell count suggest potential respiratory issues, but the SpO2 of 99% and normal respiratory rate suggest that the patient is currently not in severe respiratory distress. However, the presence of diffuse wheezing and the need for oxygen therapy indicate that the patient requires close monitoring for potential respiratory failure. Based on the provided information, the patient's condition does not currently meet the full criteria for respiratory failure, but the patient is at risk and requires close monitoring."
195261.txt,"Assessment and Plan
 CONSTIPATION (OBSTIPATION, FOS)
 IMPAIRED SKIN INTEGRITY
 .H/O CIRRHOSIS OF LIVER, ALCOHOLIC
 .H/O LYMPHOMA (CANCER, MALIGNANT NEOPLASM, LYMPHOID)
 .H/O PAIN CONTROL (ACUTE PAIN, CHRONIC PAIN)
 HYPOTENSION (NOT SHOCK)
 NEUTROPENIA
   .
   52 yoF with Lymphoplasmacytic lymphoma, Waldenstrom's
   macroglobulinemia, hepatitis C, h/o hepatitis B, and cryoglobulinemia
   admitted with new onset rash and transferred to the [**Hospital Unit Name 44**] for
   hypotension in the setting of neutropenia.",Hypotension:; # Rash:; Pancytopenia:; lymphoplasmocytic lymphoma:,"PHERESIS CATHETER - START [**2123-7-30**] 04:34 PM
.
- pheresis catheter placed by IR and completed one round of pheresis,
next one Sunday AM
- blood cx grew cornyebacterium
- newly requiring 2L O2 by nasal canula
Codeine
Hives;
Latex
Rash;
Changes to
f
Review of systems is unchanged from admission except as noted below
Review of systems:","Last dose of Antibiotics:
Vancomycin - [**2123-7-30**] 08:45 PM
Cefipime - [**2123-7-31**] 12:08 AM
Infusions:
Other ICU medications:
Other medications:
Flowsheet Data as of  [**2123-7-31**] 07:53 AM
Vital signs
Hemodynamic monitoring
Fluid balance
24 hours
Since 12 AM
Tmax: 36.3
C (97.3
Tcurrent: 35.9
C (96.6
HR: 85 (72 - 88) bpm
BP: 92/52(69) {92/52(69) - 146/89(108)} mmHg
RR: 19 (12 - 28) insp/min
SpO2: 95%
Heart rhythm: SR (Sinus Rhythm)
Total In:
2,451 mL
179 mL
PO:
200 mL
TF:
IVF:
2,016 mL
179 mL
Blood products:
235 mL
Total out:
765 mL
316 mL
Urine:
765 mL
316 mL
NG:
Stool:
Drains:
Balance:
1,686 mL
-137 mL
Respiratory support
O2 Delivery Device: Nasal cannula
SpO2: 95%
ABG: 7.44/26/62/23/-4 (respiratory alkalosis)
Gen: Pleasant, well appearing, NAD
HEENT: No conjunctival lesions. No icterus. MMM. OP clear without
mucosal ulcers or other lesions.
NECK: Supple, palpable mass in L submandibular region which patient
states is clogged salivary gland. JVP low.
CV: RRR. nl S1, S2. No murmurs, rubs or [**Last Name (un) 1792**]
LUNGS: CTAB. Diffuse wheezes. No rhonchi or rales.
ABD: NABS. Soft, NT, ND. No palpable HSM.
EXT: WWP, NO CCE. Full distal pulses bilaterally.
SKIN: Diffuse/ extensive non-blanching rash over her lower ext
extending to her buttock. Blanching, red/pink rash extending to
abdomen.
NEURO: A&Ox3. Appropriate. CN 2-12 grossly intact sensation throughout.
5/5 strength throughout. Non-focal exam
69 K/uL
8.1 g/dL
106 mg/dL
1.2 mg/dL
23 mEq/L
4.3 mEq/L
35 mg/dL
107 mEq/L
138 mEq/L
25.3 %
1.2 K/uL
[image002.jpg]
[**2123-7-31**] 4:13AM
[**2123-7-29**]  04:50 AM
[**2123-7-29**]  08:23 AM
[**2123-7-29**]  08:34 AM
[**2123-7-29**]  12:56 PM
[**2123-7-29**]  03:45 PM
[**2123-7-29**]  11:46 PM
[**2123-7-30**]  03:09 AM
[**2123-7-30**]  09:55 AM
[**2123-7-30**]  04:03 PM
[**2123-7-31**]  04:13 AM
WBC
0.5
0.4
0.3
0.3
1.2
Hct
31.8
26.5
27.4
28.4
25.3
Plt
48
30
31
27
73
69
Cr
1.6
1.3
1.0
0.9
1.2
TCO2
22
20
19
18
Glucose
79
86
100
112
106
Other labs: PT / PTT / INR:15.1/35.0/1.3, ALT / AST:39/54, Alk Phos / T
Bili:52/1.1, Differential-Neuts:61.0 %, Band:8.0 %, Lymph:19.0 %,
Mono:3.0 %, Eos:5.0 %, D-dimer:2153 ng/mL, Fibrinogen:395 mg/dL, Lactic
Acid:3.6 mmol/L, Albumin:2.7 g/dL, LDH:129 IU/L, Ca++:9.3 mg/dL,
Mg++:2.5 mg/dL, PO4:3.9 mg/dL
.
CXR [**2123-7-31**]: pending
.
BCx [**7-29**]: one with GPC, one with CORYNEBACTERIUM OR propionibacterium
BCx [**7-30**]: NGTD
Ucx: positive for yeast
MRSA pending",hypotension : ; # rash : ; pancytopenia : ; lymphoplasmocytic lymphoma :,Hypotension:; Number Rash:; Pancytopenia:; lymphoplasmocytic lymphoma:,clasmotocytic lymphoma;Hypotension NEC;Rash,clasmotocytic lymphoma;hypotensive,clasmotocytic lymphoma;Hypotension NEC;Rash,hypotension ; number rash ; pancytopenia ; lymphoplasmocytic lymphoma,"['hypotension', 'number rash', 'pancytopenia', 'lymphoplasmocytic lymphoma']",False,False,False,False,False,True,False,False,False,False,True,"To determine if the patient is diagnosed with respiratory failure, we need to analyze the provided subjective and objective data. The patient is newly requiring 2L O2 by nasal canula, which indicates a need for supplemental oxygen. In the objective section, the patient's vital signs show a respiratory rate (RR) of 19 breaths per minute, which is within the normal range, but the SpO2 is 95% on 2L O2, suggesting some degree of hypoxemia. The arterial blood gas (ABG) results show a pH of 7.44, PaCO2 of 26, PaO2 of 62, and an HCO3 of 23, indicating respiratory alkalosis. The presence of diffuse wheezes and the need for supplemental oxygen are concerning for respiratory failure. However, the patient's current clinical presentation, including the ability to maintain an SpO2 of 95% on 2L O2 and the absence of severe acidosis or hypercapnia, does not definitively indicate severe respiratory failure at this moment. Nonetheless, the requirement for oxygen therapy and the presence of respiratory alkalosis, along with clinical signs such as wheezing, suggest that the patient is at risk for or is experiencing some form of respiratory compromise. Given these considerations, the conclusion leans towards the patient experiencing respiratory failure, especially considering the context of recent pheresis and potential infection (indicated by blood cultures growing Corynebacterium), which could exacerbate respiratory status.",True,"To determine if the patient is experiencing respiratory failure, we need to analyze the provided subjective and objective data. The patient's history and current condition, as well as laboratory and physical examination findings, are crucial. The patient is newly requiring 2L O2 by nasal canula, which indicates a need for increased oxygen support. This could be a sign of worsening respiratory status. The arterial blood gas (ABG) results show a pH of 7.44, PaCO2 of 26, PaO2 of 62, and an SaO2 of 95% on 2L O2, which suggests respiratory alkalosis but also indicates the patient is not achieving adequate oxygenation on room air, as evidenced by the need for supplemental oxygen. The presence of diffuse wheezes and the requirement for oxygen therapy are also relevant. However, the SpO2 is at 95%, which, although on supplemental oxygen, does not alone indicate severe hypoxemia. The patient's respiratory rate (RR) is 19, which is within a relatively normal range but on the higher side for someone at rest, especially considering the need for supplemental oxygen. The white blood cell (WBC) count is elevated at 69 K/uL, which could indicate an infection or inflammatory process. The chest X-ray (CXR) is pending, which could provide more information on the patient's lung status. Given these points, we must consider if the patient's condition meets the criteria for respiratory failure, which typically involves hypoxemic (PaO2 < 60 mmHg on room air) or hypercapnic (elevated PaCO2) respiratory failure, or both, with associated clinical symptoms and signs. While the patient shows some signs concerning for respiratory distress and requires supplemental oxygen, the ABG results and clinical presentation need to be carefully evaluated to conclude respiratory failure. The patient's PaO2 of 62 on 2L O2 suggests some degree of hypoxemia, and the clinical context (need for increased oxygen, presence of wheezes) supports the concern for respiratory failure. However, the diagnosis of respiratory failure should be made considering the entire clinical picture, including the severity of hypoxemia, hypercapnia, and the patient's overall condition."
